2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 14, 2013
Grant Date -
Nov 25, 2010
app pub date -
Aug 27, 2008
filing date -
Aug 28, 2007
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides novel pyrimidine derivatives of formula (1) and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of insulin-like growth factor (IGF-1R) or anaplastic lymphoma kinase (ALK).
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully